Latest Period
Q4 2025
Security Snapshot
10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) Institutional Ownership
CUSIP: 88025U109
13F Institutional Holders and Ownership History from Q3 2019 to Q1 2026
Institutions Reporting
319
Shares (Excl. Options)
123,353,585
Price
$16.31
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / CLASS A COMMON STOCK
- Symbol
- TXG on Nasdaq
- Shares outstanding
- 118,868,985
- Price per share
- $23.27
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 123,353,585
- Total reported value
- $2,012,695,874
- % of total 13F portfolios
- 0%
- Share change
- +369,386
- Value change
- +$17,025,061
- Number of holders
- 319
- Price from insider filings
- $23.27
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- TXG - 10x Genomics, Inc. - CLASS A COMMON STOCK is tracked under CUSIP 88025U109.
- 319 institutions reported positions in Q4 2025.
- 7 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 319 to 136 between Q4 2025 and Q1 2026.
- Reported value moved from $2,012,695,874 to $670,228,262.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 319 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 88025U109?
CUSIP 88025U109 identifies TXG - 10x Genomics, Inc. - CLASS A COMMON STOCK in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 88025U109:
Significant Owners of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 16% | +44% | $355,109,205 | +$111,975,948 | 18,543,562 | +46% | FMR LLC | 27 Feb 2026 |
| VANGUARD GROUP INC | 12% | $155,176,941 | 13,274,332 | The Vanguard Group | 30 Sep 2025 | |||
| ARK Investment Management LLC | 10% | -12% | $138,963,659 | -$11,202,726 | 11,887,396 | -7.5% | ARK Investment Management LLC | 30 Sep 2025 |
| BlackRock, Inc. | 7.6% | $98,391,045 | 8,496,636 | BlackRock, Inc. | 30 Jun 2025 | |||
| Sumitomo Mitsui Trust Group, Inc. | 4.7% | -14% | $62,906,450 | -$7,397,081 | 5,381,219 | -11% | Sumitomo Mitsui Trust Group, Inc. | 30 Sep 2025 |
| Amova Asset Management Americas, Inc. | 4.7% | -14% | $62,855,762 | -$7,397,081 | 5,376,883 | -11% | Amova Asset Management Americas, Inc. | 30 Sep 2025 |
| MILLENNIUM MANAGEMENT LLC | 2.7% | -48% | $36,913,960 | -$29,821,474 | 3,060,859 | -45% | Millennium Management LLC | 30 Jun 2025 |
As of 31 Dec 2025, 319 institutional investors reported holding 123,353,585 shares of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG). This represents 104% of the company’s total 118,868,985 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) together control 81% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11% | 13,017,914 | -1.9% | 0% | $212,322,177 |
| ARK Investment Management LLC | 11% | 12,667,369 | +6.6% | 1.4% | $206,604,788 |
| FMR LLC | 10% | 11,917,482 | +41% | 0.01% | $194,374,134 |
| BlackRock, Inc. | 8.4% | 10,014,462 | +5.9% | 0% | $163,335,875 |
| Sumitomo Mitsui Trust Group, Inc. | 4.6% | 5,492,189 | +2.1% | 0.05% | $89,577,603 |
| Amova Asset Management Americas, Inc. | 4.6% | 5,486,153 | +2% | 1% | $89,424,294 |
| Quantinno Capital Management LP | 3.9% | 4,667,203 | +34% | 0.15% | $76,122,081 |
| MORGAN STANLEY | 2.7% | 3,196,893 | +13% | 0% | $52,141,338 |
| GOLDMAN SACHS GROUP INC | 2.6% | 3,087,267 | +15% | 0.01% | $50,353,325 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 2,789,784 | +2.9% | 0% | $45,509,358 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2.2% | 2,639,999 | -10% | 0.17% | $43,058,384 |
| AQR CAPITAL MANAGEMENT LLC | 2.2% | 2,579,051 | -5.4% | 0.02% | $41,857,998 |
| STATE STREET CORP | 2.1% | 2,512,519 | -0.3% | 0% | $40,979,185 |
| BANK OF AMERICA CORP /DE/ | 1.5% | 1,837,520 | -46% | 0% | $29,969,951 |
| RENAISSANCE TECHNOLOGIES LLC | 1.3% | 1,550,539 | +48% | 0.04% | $25,289,291 |
| DIMENSIONAL FUND ADVISORS LP | 1.3% | 1,517,581 | +101% | 0.01% | $24,751,651 |
| Capital World Investors | 1.2% | 1,452,300 | 0% | 0% | $23,687,013 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.2% | 1,448,765 | -66% | 0% | $23,629,358 |
| Casdin Capital, LLC | 1.2% | 1,400,000 | 1.4% | $22,834,000 | |
| T. Rowe Price Investment Management, Inc. | 1.1% | 1,279,503 | -4.7% | 0.01% | $20,869,000 |
| TWO SIGMA ADVISERS, LP | 1.1% | 1,264,900 | +5.4% | 0.04% | $20,630,519 |
| MILLENNIUM MANAGEMENT LLC | 1% | 1,242,366 | -77% | 0.01% | $20,262,989 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1% | 1,228,703 | -7% | 0.07% | $20,040,146 |
| TWO SIGMA INVESTMENTS, LP | 0.97% | 1,155,691 | +95% | 0.03% | $18,849,320 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.93% | 1,106,322 | -3.4% | 0% | $18,044,112 |
Institutional Holders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 31,580,473 | $670,228,262 | -$6,258,251 | $21.23 | 136 |
| 2025 Q4 | 123,353,585 | $2,012,695,874 | +$17,025,061 | $16.31 | 319 |
| 2025 Q3 | 122,930,411 | $1,437,019,448 | +$5,456,573 | $11.69 | 313 |
| 2025 Q2 | 122,631,794 | $1,420,549,489 | +$119,573,048 | $11.58 | 293 |
| 2025 Q1 | 113,813,127 | $993,375,835 | +$50,874,984 | $8.73 | 269 |
| 2024 Q4 | 104,507,907 | $1,500,773,196 | -$41,937,351 | $14.36 | 270 |
| 2024 Q3 | 104,345,431 | $2,355,358,198 | -$6,296,831 | $22.58 | 258 |
| 2024 Q2 | 105,353,108 | $2,048,895,776 | +$7,101,276 | $19.45 | 254 |
| 2024 Q1 | 102,897,655 | $3,861,610,085 | +$222,058,012 | $37.53 | 280 |
| 2023 Q4 | 95,956,168 | $5,370,151,466 | +$202,330,286 | $55.96 | 267 |
| 2023 Q3 | 90,883,461 | $3,748,861,587 | +$66,054,684 | $41.25 | 252 |
| 2023 Q2 | 89,127,845 | $4,977,465,562 | -$57,613,061 | $55.84 | 269 |
| 2023 Q1 | 90,187,979 | $5,027,414,812 | +$211,396,981 | $55.79 | 255 |
| 2022 Q4 | 87,545,856 | $3,190,400,302 | +$104,674,768 | $36.44 | 253 |
| 2022 Q3 | 86,068,255 | $2,449,753,227 | -$43,840,073 | $28.48 | 208 |
| 2022 Q2 | 86,085,516 | $3,909,380,180 | +$83,806,084 | $45.25 | 228 |
| 2022 Q1 | 82,769,403 | $6,293,794,627 | -$74,133,769 | $76.07 | 286 |
| 2021 Q4 | 79,764,587 | $11,861,468,865 | +$65,047,101 | $148.96 | 347 |
| 2021 Q3 | 78,759,967 | $11,461,957,413 | +$127,530,777 | $145.58 | 317 |
| 2021 Q2 | 77,884,791 | $15,246,137,868 | +$1,517,689,271 | $195.82 | 332 |
| 2021 Q1 | 70,505,001 | $12,760,866,584 | +$832,242,795 | $181.00 | 310 |
| 2020 Q4 | 66,229,914 | $9,377,686,882 | -$749,751,524 | $141.60 | 299 |
| 2020 Q3 | 69,088,795 | $8,545,655,879 | +$1,071,434,021 | $124.68 | 215 |
| 2020 Q2 | 61,004,107 | $5,448,595,110 | +$1,160,387,284 | $89.31 | 141 |
| 2020 Q1 | 38,929,050 | $2,426,163,019 | +$612,574,707 | $62.32 | 102 |
| 2019 Q4 | 30,795,732 | $2,348,169,329 | +$108,804,039 | $76.25 | 85 |
| 2019 Q3 | 22,339,937 | $1,125,942,955 | +$1,125,942,955 | $50.40 | 92 |